DALIESQ Trademark

Trademark Overview

On Tuesday, October 27, 2009, a trademark application was filed for DALIESQ with the United States Patent and Trademark Office. The USPTO has given the DALIESQ trademark a serial number of 77858894. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 1, 2013. This trademark is owned by Genentech, Inc.. The DALIESQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular diseases, atherosclerosis and dyslipidemia
daliesq

General Information

Serial Number77858894
Word MarkDALIESQ
Filing DateTuesday, October 27, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 1, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular diseases, atherosclerosis and dyslipidemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 3, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, July 1, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 1, 2013ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 9, 2012EXTENSION 5 GRANTED
Wednesday, November 7, 2012EXTENSION 5 FILED
Wednesday, November 7, 2012TEAS EXTENSION RECEIVED
Tuesday, May 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 21, 2012EXTENSION 4 GRANTED
Friday, May 18, 2012EXTENSION 4 FILED
Friday, May 18, 2012TEAS EXTENSION RECEIVED
Saturday, November 19, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 18, 2011EXTENSION 3 GRANTED
Tuesday, November 15, 2011EXTENSION 3 FILED
Tuesday, November 15, 2011TEAS EXTENSION RECEIVED
Friday, May 13, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 12, 2011EXTENSION 2 GRANTED
Tuesday, May 10, 2011EXTENSION 2 FILED
Tuesday, May 10, 2011TEAS EXTENSION RECEIVED
Wednesday, November 10, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 9, 2010EXTENSION 1 GRANTED
Thursday, October 28, 2010EXTENSION 1 FILED
Tuesday, November 9, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 28, 2010TEAS EXTENSION RECEIVED
Tuesday, June 1, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 6, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Friday, February 26, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 26, 2010ASSIGNED TO LIE
Monday, February 1, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, January 31, 2010ASSIGNED TO EXAMINER
Tuesday, November 3, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 30, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

daliesq atherosclerosis dyslipidemia diseases cardiovascular preparations treatment pharmaceutical